XML 121 R29.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation
12 Months Ended
Dec. 31, 2019
Stock-Based Compensation  
Stock-Based Compensation

NOTE U. STOCK-BASED COMPENSATION

The following table presents total stock-based compensation cost included in income from continuing operations.

($ in millions)

For the year ended December 31:

    

2019

    

2018

    

2017

Cost

$

100

$

82

$

91

Selling, general and administrative

453

361

384

Research, development and engineering

126

67

59

Pre-tax stock-based compensation cost

679

510

534

Income tax benefits

(155)

(116)

(131)

Net stock-based compensation cost

$

524

$

393

$

403

Total unrecognized compensation cost related to non-vested awards at December 31, 2019 was $1.2 billion and is expected to be recognized over a weighted-average period of approximately 2.5 years.

Capitalized stock-based compensation cost was not material at December 31, 2019, 2018 and 2017.

Incentive Awards

Stock-based incentive awards are provided to employees under the terms of the company’s long-term performance plans (the Plans). The Plans are administered by the Executive Compensation and Management Resources Committee of the Board of Directors. Awards available under the Plans principally include restricted stock units, performance share units, stock options or any combination thereof.

There were 273 million shares originally authorized to be awarded under the company's existing Plans and 66 million shares granted under previous plans that, if and when those awards were cancelled, could be reissued under the existing Plans. At December 31, 2019, 94 million unused shares were available to be granted.

Stock Awards

Stock awards are made in the form of Restricted Stock Units (RSUs), including Retention Restricted Stock Units (RRSUs), or Performance Share Units (PSUs).

The following table summarizes RSU and PSU activity under the Plans during the years ended December 31, 2019, 2018 and 2017.

RSUs

PSUs

Weighted-Average

Weighted-Average

    

Grant Price

    

Number of Units

    

Grant Price

    

Number of Units

Balance at January 1, 2017

$

147

8,899,092

$

155

2,874,758

Awards granted

137

3,540,949

137

824,875

Awards released

153

(3,032,531)

175

(293,236)

Awards canceled/forfeited/performance adjusted

147

(852,247)

170

(757,084)

*

Balance at December 31, 2017

$

141

8,555,263

$

144

2,649,313

**

Awards granted

121

4,806,790

130

909,140

Awards released

148

(2,579,962)

152

(666,244)

Awards canceled/forfeited/performance adjusted

139

(979,387)

147

(472,514)

*

Balance at December 31, 2018

$

130

9,802,704

$

136

2,419,695

**

Awards granted

119

5,650,861

117

1,395,534

Awards released

136

(3,145,016)

140

(846,672)

Awards canceled/forfeited/performance adjusted

128

(981,921)

131

(112,107)

*

Balance at December 31, 2019

$

123

11,326,628

$

126

2,856,450

**

*   Includes adjustments of (8,544), (328,120) and (623,245) PSUs for 2019, 2018 and 2017, respectively, because final performance metrics were above or below specified targets.

** Represents the number of shares expected to be issued based on achievement of grant date performance targets. The actual number of shares issued will depend on final performance against specified targets over the vesting period.

The total fair value of RSUs and PSUs granted and vested during the years ended December 31, 2019, 2018 and 2017 were as follows:

($ in millions)

For the year ended December 31:

    

2019

    

2018

    

2017

RSUs

Granted

$

674

$

583

$

484

Vested

428

381

463

PSUs

Granted

$

164

$

118

$

113

Vested

118

101

51

As of December 31, 2019, there was $1.1 billion of unrecognized compensation cost related to non-vested RSUs, which will be recognized on a straight-line basis over the remaining weighted-average contractual term of approximately 2.5 years.

In connection with vesting and release of RSUs and PSUs, the tax benefits realized by the company for the years ended December 31, 2019, 2018 and 2017 were $131 million, $117 million and $180 million, respectively.

Stock Options

In 2016, the company made one grant of 1.5 million premium-priced stock options. The option award was granted with a three-year cliff vesting period and a 10-year contractual term. The award’s cost of $12 million was recognized ratably over the three-year vesting period. As of December 31, 2019, these options were vested with a weighted-average exercise price of $140 per share and had a remaining weighted-average contractual life of approximately 6.1 years. The options were exercisable within a range of $129 to $154. The total intrinsic value of these vested options as of December 31, 2019 was $1.9 million.

The company has not granted options since 2016. No stock options were exercised, forfeited or canceled during the years ended December 31, 2019 and 2018. The total intrinsic value of options exercised during the year ended December 31, 2017 was $7 million. In connection with this exercise, $11 million in cash was received from employees and the company realized a tax benefit of $2 million.

The company settles employee stock option exercises primarily with newly issued common shares and, occasionally, with treasury shares. Total treasury shares held at December 31, 2019 and 2018 were approximately 1,351 million and 1,341 million shares, respectively.

Acquisitions

In connection with the acquisition of Red Hat, the company issued and assumed 6.4 million stock awards with a fair value of $845 million. A share conversion ratio of 1.35 was applied to convert Red Hat’s outstanding equity awards for Red Hat’s common stock into IBM stock awards. At December 31, 2019, there were 4.6 million of these stock awards outstanding with a weighted-average grant price of $140 per share.

In connection with various other acquisition transactions, there was an additional 0.1 million stock options outstanding at December 31, 2019, as a result of the company’s conversion of stock-based awards previously granted by acquired entities. The weighted-average exercise price of these awards was $43 per share.

IBM Employees Stock Purchase Plan

The company maintains a non-compensatory Employees Stock Purchase Plan (ESPP). The ESPP enables eligible participants to purchase shares of IBM common stock at a 5 percent discount off the average market price on the day of purchase through payroll deductions of up to 10 percent of eligible compensation. Eligible compensation includes any compensation received by the employee during the year. The ESPP provides for semi-annual offering periods during which shares may be purchased and continues as long as shares remain available under the ESPP, unless terminated earlier at the discretion of the Board of Directors. Individual ESPP participants are restricted from purchasing more than $25,000 of common stock in one calendar year or 1,000 shares in an offering period.

Employees purchased approximately 1.0 million shares under the ESPP during each year ended December 31, 2019, 2018 and 2017. Cash dividends declared and paid by the company on its common stock also include cash dividends on the company stock purchased through the ESPP. Dividends are paid on full and fractional shares and can be reinvested. The company stock purchased through the ESPP is considered outstanding and is included in the weighted-average outstanding shares for purposes of computing basic and diluted earnings per share.

Approximately 18.8 million shares were available for purchase under the ESPP at December 31, 2019.